DIAGNOS (CVE:ADK) Director Michael Braeuel Buys 53,571 Shares

DIAGNOS Inc. (CVE:ADK) Director Michael Braeuel purchased 53,571 shares of the company’s stock in a transaction that occurred on Thursday, July 30th. The stock was acquired at an average price of C$0.28 per share, for a total transaction of C$14,999.88. Following the purchase, the director owned 2,148,880 shares in the company, valued at C$601,686.40. This trade represents a 2.56% increase in their position.

Michael Braeuel also recently made the following trade(s):

• On Thursday, July 30th, Michael Braeuel acquired 50,000 shares of DIAGNOS stock. The shares were bought at an average cost of C$0.28 per share, with a total value of C$14,000.00.
• On Thursday, July 30th, Michael Braeuel acquired 25,000 shares of DIAGNOS stock. The stock was bought at an average price of C$0.28 per share, for a total transaction of C$7,000.00.

DIAGNOS Stock Performance

Shares of ADK traded up C$0.01 during trading hours on Friday, hitting C$0.28. The company had a trading volume of 35,149 shares, compared to its average volume of 210,613. The firm has a market cap of C$33.72 million, a price-to-earnings ratio of -7.00 and a beta of -0.12. The business has a fifty day moving average of C$0.23 and a 200-day moving average of C$0.26. DIAGNOS Inc. has a 12 month low of C$0.17 and a 12 month high of C$0.41. The company has a quick ratio of 0.68, a current ratio of 1.49 and a debt-to-equity ratio of 204.05.

DIAGNOS Company Profile

DIAGNOS Inc provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence.